| Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
|---|---|---|---|---|---|
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 2042 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 2274 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 3579 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 5109 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 5110 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 5224 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 5539 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 5851 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 5907 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6027 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6055 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6233 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6479 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6694 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6823 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6909 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6946 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 6975 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7078 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7147 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7153 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7197 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7241 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7256 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7304 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7455 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7508 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7516 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7540 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7581 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7739 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7751 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 7928 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8070 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8100 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8254 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8311 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8391 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8455 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8532 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8585 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8658 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8732 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8749 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 8942 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9128 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9183 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9238 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9248 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9267 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9314 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9328 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9332 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9406 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9436 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9468 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9639 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9652 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9673 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9700 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9713 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9837 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9839 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9968 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 9991 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10017 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10105 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10154 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10173 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10240 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10382 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10429 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10493 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10561 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10585 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10701 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10740 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10760 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10762 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10859 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 10891 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11031 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11040 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11056 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11126 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11176 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11179 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11219 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11228 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11264 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11389 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11392 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11439 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11537 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11568 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11596 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11773 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11781 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11792 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11820 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11827 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11869 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11902 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11904 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11952 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 11964 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12000 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12020 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12035 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12066 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12103 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12169 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12211 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12322 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12342 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12381 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12541 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12565 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12622 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12667 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12672 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12884 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12889 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12899 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12903 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12938 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 12989 | Peak area normalized | chear plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13022 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13049 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13117 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13312 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13359 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13457 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13478 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13483 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13597 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13598 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13599 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13613 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13659 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13663 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13692 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13704 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13706 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13760 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13769 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13790 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13797 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13804 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13821 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13830 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13838 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13844 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13852 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13865 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13872 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13909 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13914 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13921 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 13944 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14008 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14015 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14056 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14057 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14066 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14071 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14120 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14121 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14142 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14189 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14198 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14218 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14244 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14255 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14260 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14268 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14286 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14340 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14344 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14360 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14428 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14461 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14504 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14516 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14531 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14601 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14602 | Peak area normalized | master pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14610 | Peak area normalized | batch pool | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14629 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14659 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14738 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14880 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 14975 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 15041 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 15116 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 15541 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 15822 | Peak area normalized | red cross plasma | - |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 15840 | Peak area normalized | Sample | male |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 15852 | Peak area normalized | Sample | female |
| Reversed Phase POSITIVE (Named metabolites) | indole-3-methyl acetate | 15868 | Peak area normalized | Sample | male |
Return to search page
